# A SAD and MAD Study of the Safety, Tolerability, and Pharmacokinetics of ATH-1105

> **NCT06432647** · PHASE1 · COMPLETED · sponsor: **LeonaBio** · enrollment: 80 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ATH-1105
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06432647
- **Lead sponsor:** LeonaBio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-24
- **Primary completion:** 2024-11-25
- **Final completion:** 2024-11-25
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06432647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06432647, "A SAD and MAD Study of the Safety, Tolerability, and Pharmacokinetics of ATH-1105". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06432647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*